Neptune Medical, a Burlingame, CA-based leader in medical device innovation, announced theì spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97m Series D financing.
Sonder Capital and Olympus Corporation of the Americas were significant participants in this round, along with investments from other existing and new investors.
This financing will strengthen Neptune Medical as a gastrointestinal-focused company expanding into robotics for GI disease, as evidenced by the recent appointment of medical robotics pioneer Dr. Fred Moll as Chairman of the Board. It will also enable Jupiter Endovascular to focus on its novel endovascular technology platform.
Jupiter Endovascular is developing a new class of endovascular procedures to bring the precision and control of direct surgical access to catheter-based interventions.
FinSMEs
15/08/2024